PROCEPT BioRobotics (PRCT) Misses Q4 EPS by 21c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall St falls as oil ticks up, yields rise ahead of US-China summit
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil holds near two-week lows while diesel cracks hit record
- On Holding sets 2029 financial targets, authorizes $1B share buyback
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Nasdaq reaches record high close, AI stocks rally
- Elmet Group signs tungsten offtake deal with Hemerdon Mine
- Meta bull case increasingly playing out, Mizuho says
TD Cowen on Procept BioRobotics Corp (PRCT): 'We are constructive after the big stock decline'
February 26, 2026 3:05 PM ESTTD Cowen analyst Joshua Jennings reiterated a Buy rating and $34.00 price target on Procept BioRobotics Corp (NASDAQ: PRCT).
The analyst comments "We are constructive after the big stock decline that followed the Q4 report. PRCT again made a strong case to justify its recent... More
